Oral macrophage-like cells play a key role in tolerance induction following sublingual immunotherapy of asthmatic mice (Q84580187)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775981%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

Oral macrophage-like cells play a key role in tolerance induction following sublingual immunotherapy of asthmatic mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775981%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775981%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Y C Lone

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775981%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Daniel Ladant

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775981%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

L Mascarell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775981%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

N Saint-Lu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775981%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

H Moussu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775981%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

A Louise

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775981%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

C Leclerc

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775981%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

S Tourdot

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775981%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

L Van Overtvelt

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775981%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

P Moingeon

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775981%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

publication date

20 July 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775981%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775981%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775981%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775981%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

638-647

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21775981%20AND%20SRC:MED&resulttype=core&format=json

Production of salivary immunoglobulin A and suppression of Dermatophagoides pteronyssinus-induced airway inflammation by local nasal immunotherapy

8 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen Bet v 1.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

In vivo and in vitro immunomodulation of Der p 1 allergen-specific response by Lactobacillus plantarum bacteria

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

CpG Immunotherapy in Chenopodium album sensitized mice: The comparison of IFN-gamma, IL-10 and IgE responses in intranasal and subcutaneous administrations

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Inhibition of airway allergic disease by co-administration of flagellin with allergen

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Airway inflammation induced after allergic poly-sensitization can be prevented by mucosal but not by systemic administration of poly-peptides.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

The role of Foxp3+ T cells in long-term efficacy of prophylactic and therapeutic mucosal tolerance induction in mice.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Oral tolerance: therapeutic implications for autoimmune diseases

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

CD4+CD25- T cells that express latency-associated peptide on the surface suppress CD4+CD45RBhigh-induced colitis by a TGF-beta-dependent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Latency-associated peptide identifies a novel CD4+CD25+ regulatory T cell subset with TGFbeta-mediated function and enhanced suppression of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Novel ways for immune intervention in immunotherapy: mucosal allergy vaccines

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Improvement of sublingual immunotherapy efficacy with a mucoadhesive allergen formulation.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

A synthetic triacylated pseudo-dipeptide molecule promotes Th1/TReg immune responses and enhances tolerance induction via the sublingual route

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

B lymphocytes promote expansion of regulatory T cells in oral tolerance: powerful induction by antigen coupled to cholera toxin B subunit

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Oral dendritic cells mediate antigen-specific tolerance by stimulating TH1 and regulatory CD4+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

IL-10-inducing adjuvants enhance sublingual immunotherapy efficacy in a murine asthma model

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Targeting the allergen to oral dendritic cells with mucoadhesive chitosan particles enhances tolerance induction.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Sublingual immunotherapy for allergic rhinitis

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Safety of sublingual immunotherapy in children with asthma.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Efficacy and safety of sublingual immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Efficacy and safety of 5-grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Immune mechanisms of allergen-specific sublingual immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Dendritic cells as potential targets for mucosal immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Mapping of the lingual immune system reveals the presence of both regulatory and effector CD4+ T cells.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Enhancement of protective efficacy following intranasal immunization with vaccine plus a nontoxic LTK63 mutant delivered with nanoparticles

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b/CD18)

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

The adenylate cyclase of Bordetella pertussis: a vector to target antigen presenting cells.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Induction of interleukin 10 by sublingual immunotherapy for house dust mites: a preliminary report

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Characterization of dendritic cells from human oral mucosa: a new Langerhans' cell type with high constitutive FcepsilonRI expression.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Engagement of Fc epsilon RI on human monocytes induces the production of IL-10 and prevents their differentiation in dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Toll-like receptor 4 ligation enforces tolerogenic properties of oral mucosal Langerhans cells

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Distribution of Langerhans cells and mast cells within the human oral mucosa: new application sites of allergens in sublingual immunotherapy?

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Immune mechanisms of sublingual immunotherapy: are oral Langerhans cells the masters of tolerance?

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Phl p 5 resorption in human oral mucosa leads to dose-dependent and time-dependent allergen binding by oral mucosal Langerhans cells, attenuates their maturation, and enhances their migratory and TGF-beta1 and IL-10-producing properties

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Induction of a polarized Th1 response by insertion of multiple copies of a viral T-cell epitope into adenylate cyclase of Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Antigen targeting to CD11b allows efficient presentation of CD4+ and CD8+ T cell epitopes and in vivo Th1-polarized T cell priming

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Delivery of the HIV-1 Tat protein to dendritic cells by the CyaA vector induces specific Th1 responses and high affinity neutralizing antibodies in non human primates.

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

The regulation of IL-10 production by immune cells

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Integrin CD11b negatively regulates TLR-triggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021

Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity

1 reference

https://api.crossref.org/works/10.1038%2FMI.2011.28

7 January 2021